CAR-T cells targeting EpCAM, which is upregulated in ovarian cancer, CRC, and peritoneal carcinomatosis, have shown remarkable success in eliminating EpCAM-expressing cancer cells [279,280]. The gene discussed is EPCAM; the disease is cancer.